CannabisNewsBreaks

FridaySep 21, 2018 1:46 pm

CannabisNewsBreaks – The Flowr Corp. and The Needle Capital Corp. Successfully Complete Qualifying Transaction

The Flowr Corp., a vertically-integrated Canadian licensed producer that focuses primarily on premium flower production, together with The Needle Capital Corp., this morning announced the successful completion of the qualifying transaction under the policies of the TSX Venture Exchange (the “TSXV”). In accordance with a business combination agreement entered into between Needle, Flowr and 2652253 Ontario Inc. ("Subco"), Needle and Flowr completed a transaction that resulted in a reverse takeover of Needle by the shareholders of Flowr to form the resulting issuer. Flowr and Needle attained conditional approval for the transaction from the TSXV on September 12, 2018 and the…

Continue Reading

FridaySep 21, 2018 9:30 am

CannabisNewsBreaks – Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) Applauds Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Commencement of Trading on the TSX Venture Exchange

Canopy Growth (TSX: WEED) (NYSE: CGC) recently congratulated the Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) team for its commencement of trading on the TSX Venture Exchange under the ticker symbol “RIV” on September 20, 2018. Canopy Rivers, a unique investment and operating platform designed to pursue investment opportunities in the emergent global cannabis sector, was originally founded to diversify Canopy Growth's cannabis supply streams. Canopy Rivers rapidly progressed into a worldwide strategic growth platform that builds value in cannabis venture partners by supporting each stage, from licensing and genetics to financial and strategic support, leveraging its affiliation with Canopy Growth.…

Continue Reading

ThursdaySep 20, 2018 4:51 pm

CannabisNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Initiates Trading on the TSX Venture Exchange

Canopy Rivers (TSX.V: RIV) (OTC: CNPOF), a unique investment and operating platform designed to pursue investment opportunities in the emergent global cannabis sector, this morning began trading its subordinated voting shares on the TSX Venture Exchange under the ticker symbol "RIV." In a news release issued on September 17, 2018, Canopy Rivers reported the successful completion of its qualifying transaction. The transaction consisted of a three-cornered amalgamation involving the company’s wholly owned 10859150 Canada Inc. subsidiary merging with Canopy Rivers Corporation.  Canopy closed its first day of trading at $8.75 on volume of more than 18 million. To view the…

Continue Reading

WednesdaySep 19, 2018 12:35 pm

CannabisNewsBreaks – Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) Has Achieved DTC, CNS Eligibility to Simplify Settlement, Boost Liquidity

Phivida Holdings (CSE: VIDA) (OTCQX: PHVAF), a premium functional food and beverage business based in Vancouver, British Columbia, was recently awarded full DTC (Depository Trust Company) and CNS (Continuous-Net-Settlement) eligibility for its common shares listed for trading on the U.S. OTCQX® Best Market. A recent article discussing this reads, “Phivida’s expectation is that achieving DTC and CNS eligibility will simplify and fast-track settlement for investors while boosting the liquidity of its common shares on the OTC Market. CNS eligibility ensures that all DTC eligible trades and cash balances are centralized, cleared and settled in an efficient and systematic way.” To…

Continue Reading

WednesdaySep 19, 2018 9:27 am

CannabisNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Appoints Leading Cannabis Legalization Advocate to Board of Advisors

FinCanna Capital (CSE: CALI) (OTCQB: FNNZF), a royalty company for the U.S. licensed medical cannabis industry, this morning announced the appointment of Ms. Rosy Mondin, a leading advocate for the legalization of adult use cannabis in Canada, to its Board of Advisors. Mondin co-founded Soma Labs Scientific in 2014, which amalgamated to form Quadron Cannatech Corporation in 2016. Mondin serves as CEO and director Quadron Cannatech Corporation, making her the first woman to hold the role of CEO in a publicly traded company in the cannabis sector. “We are honored to have a woman with Rosy’s in-depth industry knowledge join…

Continue Reading

TuesdaySep 18, 2018 12:49 pm

CannabisNewsBreaks – The Coca-Cola Co. (NYSE: KO) Evaluates Opportunity in the Evolving Cannabis Market

Coca-Cola (NYSE: KO) is the latest beverage company assessing its options in the ever-evolving cannabis market and is presently in talks with Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF), according to BNN Bloomberg. A recent article by Jen Skerritt and Craig Giammona on Bloomberg.com titled, “Coca-Cola Is Eyeing the Cannabis Market” highlights the company’s potential decision to join the growing ranks of mainstream businesses investing in the cannabis sector. Per the article, Coca-Cola is particularly interested in drinks infused with non-psychoactive cannabinoid (“CBD”). “We are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around…

Continue Reading

TuesdaySep 18, 2018 9:27 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Applies for Master Retail License in Manitoba’s Request for Proposal

British Columbia-based cannabis cultivation firm Choom Holdings (CSE: CHOO) (OTCQB: CHOOF) this morning announced that it has applied for a master retail license in Manitoba's Request for Proposal ("RFP") to sell recreational cannabis following the upcoming recreational legalization on October 17th. If granted, the license would enable Choom to run an e-commerce platform and operate retail cannabis stores within the province. "Manitoba represents another step in our strategy to build one of the largest private retail networks across Canada and establishing Choom as a dominant Canadian cannabis brand. The RFP process is highly competitive and receiving one of the master…

Continue Reading

FridaySep 14, 2018 2:34 pm

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Revolutionizes Visibility, IP Protection in the Cannabis Supply Chain

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF), through its easily integrated BLOCKStrain platform, enables cannabis growers to defend their intellectual property rights with an authentic, verifiable chain of evidence embedded in the blockchain from genome to sale. A recent article discussing the company reads: “That’s where BLOCKStrain’s platform comes in by providing a gene-registration defense of intellectual property rights and establishing historical proof of ownership. That’s huge for cannabis growers seeking to develop their own brands for an increasingly astute and knowledgeable base of loyal consumers. The authenticity of a particular cannabis strain is followed from genome to sale, providing…

Continue Reading

FridaySep 14, 2018 11:32 am

CannabisNewsBreaks – Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) Unveils New Beverage Line

Koios Beverage Corp. (CSE: KBEV) (OTC: KBEVF) develops and distributes nature-based products that boost brain function, elevate health, and enhance productivity. The company recently launched the first two flavors in its new line of beverages. A recent article discussing the beverages reads: “Pear guava has proven so popular that the company is in its second run of production. The other flavor is peach mango. Both beverages include the new superfood lion’s mane mushroom, which is part of Koios’ reformulated and improved range of cognitive-enhancing drinks. Other flavors soon to come in the same line are blood orange and apricot vanilla.”…

Continue Reading

FridaySep 14, 2018 11:26 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advances Nature Identical Peptides Testing

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is steadfast in its mission of developing preventive therapies for health-conscious consumers who want nature-based products. A recent article discussing the company reads, “In recent months, the company has advanced the testing of its Nature Identical™ peptides toward the treatment and prevention of cancers such as the glioblastoma, the disease that took the life of Sen. John McCain. The company’s research team identified eight peptide candidates for the anticipated line of wellness products earlier this year, building on analysis of the Caribbean blue scorpion whose venom is widely reputed…

Continue Reading